Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000079

CEO bought 7,000 shares at an average $0.13 ($900)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-01-13 Purchase : show line 1 in the form +2,000 $0.14 $280 6,938,314 D
2016-01-15 Purchase : show line 2 in the form +5,000 $0.12 $620 6,943,314 D
Open-market purchases · 7,000 sh · avg $0.13 · $900
Loading xslF345X03/primary_doc.xml…